Nigella sativa supplementation to treat symptomatic mild COVID-19: A structured summary of a protocol for a randomised, controlled, clinical trial

Peer Review reports

Original Submission
30 Jul 2020	Submitted	Original manuscript
30 Jul 2020	Reviewed	Reviewer Report - Kirsty Loudon
Resubmission - Version 2
	Submitted	Manuscript version 2
Publishing
30 Jul 2020	Editorially accepted
8 Aug 2020	Article published	10.1186/s13063-020-04647-x

Back to article page